IP Library Granted Patent US 12673973
Granted Patent B2
US 12673973 · App. 18/285,543 · Granted Jul 7, 2026

Peptide having blood coagulation activity, and use thereof

Inventors: Yong Ji Chung (Anyang-si, KR); Eun Mi Kim (Anyang-si, KR); Mihee Cho (Anyang-si, KR); Kyeongnan Kwon (Anyang-si, KR)
Assignee: CAREGEN CO, LTD.
C07K7/08A61K33/06A61K38/10A61P7/04A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12673973
App. No.
18/285,543
Granted
Jul 7, 2026
Kind
B2
Abstract

The present invention relates to a peptide, of a novel sequence, characterized by being gelled in accordance with the pH condition. Since the peptide may induce blood coagulation, a composition comprising the peptide can be utilized for the use of inducing hemostasis.

Claims (11)

1 . A peptide having pH-dependent gelation property, which comprises the amino acid sequence of SEQ ID NO: 1.

2 . The peptide according to claim 1 , wherein the peptide gelates at pH 4 to pH 8.

3 . The peptide according to claim 1 , wherein the peptide can induce blood coagulation.

4 . A composition for inducing hemostasis, comprising the peptide of claim 1 .

5 . The composition for inducing hemostasis according to claim 4 , wherein the peptide is contained in the composition at a concentration of 0.5 mg/ml to 50 mg/ml.

6 . The composition for inducing hemostasis according to claim 4 , wherein the composition further comprises calcium ions.

7 . The composition for inducing hemostasis according to claim 4 , wherein the composition coagulates blood at pH 4 to pH 8.

8 . The composition for inducing hemostasis according to claim 4 , wherein the composition coagulates blood under the condition that the salt concentration is 50 mM or more.

9 . The composition for inducing hemostasis according to claim 4 , wherein the composition does not cause hemolysis.

10 . The composition for inducing hemostasis according to claim 4 , wherein the composition is in the form of at least one selected from the group consisting of powder formulations, patches, gauze, sprays and injections.

11 . A method for hemostasis comprising the step of treating the composition of claim 4 to a bleeding site of an animal in which bleeding occurs.